Logo_Anaqua-Color.png
Anaqua Transforms Foreign Patent Filing into a Strategic Advantage for Intellectual Property Professionals
18 avr. 2024 07h00 HE | Anaqua
Anaqua revolutionizes IP management with enhanced Foreign Filing in AQX®, empowering swift global protection decisions.
Logo_Anaqua-Color.png
Isuzu Motors Limited Drives Forward with Anaqua as Intellectual Property Management Provider
16 avr. 2024 08h00 HE | Anaqua
Anaqua announces global commercial vehicle manufacturer Isuzu Motors as new intellectual property management software client.
gbtlogo.jpg
GBT Technologies Adapts Pioneering Apollo Technology for Next-Generation Counter-Drone System
11 avr. 2024 08h30 HE | GBT Technologies Inc.
SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- GBT Technologies Inc. (OTC PINK: GTCH) (the “Company”) has recently announced the use in a testing scenario of its innovative Apollo computer vision...
Logo_Anaqua-Color.png
Anaqua améliore sa plateforme de recherche de brevets AcclaimIP en ajoutant des capacités basées sur l'IA
08 avr. 2024 09h37 HE | Anaqua
BOSTON, 08 avr. 2024 (GLOBE NEWSWIRE) -- Anaqua, le leader des technologies de gestion de la propriété intellectuelle (PI) et de l’innovation, continue d'améliorer sa puissante plateforme de...
Logo_Anaqua-Color.png
Anaqua Enhances AcclaimIP Patent Search with AI-Powered Capabilities
08 avr. 2024 09h37 HE | Anaqua
Anaqua revolutionizes patent search with AI-powered AcclaimIP. Explore over 100M patents worldwide with user-friendly interface and cutting-edge AI.
gbtlogo.jpg
Bannix and GBT Partner to Bring Revolutionary Imaging Tech "VisionWave" to Market
28 mars 2024 10h03 HE | GBT Technologies Inc.
Enter into Binding Business Combination Agreement WEST HOLLYWOOD, Calif., March 28, 2024 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. (“Bannix” or the “Company”) together with GBT Technologies,...
Logo 1-1.png
Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis
25 mars 2024 07h06 HE | Chemomab Therapeutics
Chemomab has gained a new EU patent for CM-101 covering its use in liver diseases including PSC, adding to the robust patent estate in major territories.
Picture3.jpg
Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China
19 mars 2024 07h55 HE | Clearmind Medicine Inc.
A Novel Approach to Combatting Binge Behaviors with Groundbreaking Psychedelic Therapy Tel Aviv, Israel / Vancouver, Canada, March 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq:...
scilogo.jpg
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
18 mars 2024 07h29 HE | SciSparc Ltd
TEL AVIV, Israel, March 18, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of...
White Filament LED Bulbs
Feit Electric Announces Second Patent Enforcement Action Against Infringing White LED Filaments
13 mars 2024 16h20 HE | Feit Electric
Feit Electric Company, Inc. today commenced a second white filament patent infringement action against Savant Technologies doing business as GE Lighting